<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02049411</url>
  </required_header>
  <id_info>
    <org_study_id>R-2012-3601-56</org_study_id>
    <nct_id>NCT02049411</nct_id>
  </id_info>
  <brief_title>Ketamine and Changes of the Short Portable Mental Status Questionnaire</brief_title>
  <acronym>SPMSQ-E</acronym>
  <official_title>Changes of the Short Portable Mental Status Questionnaire (SPMSQ-E) After Ketamine Administration on Ophthalmic Surgery in Geriatric Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Mexicano del Seguro Social</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Polytechnic Institute, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Mexicano del Seguro Social</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      - Cognitive changes are related to aging, affecting the performance of older patients in the
      solution of problems and the execution of tasks.

      This phenomenon has been observed as a decline of neurophysiological domains, especially
      memory, and the velocity of thought.

        -  Anesthesia and surgery performed contributes to its development then, is named
           post-operative cognitive dysfunction (POCD). The incidence varies due to conditions of:

             1. Anesthesia and surgery.

             2. The time elapsed after surgery.

             3. The population studied, and the type of cognitive test employed.

        -  The aim of this study is to evaluate the changes around the Short Portable Mental Status
           Questionnaire (SPMSQ-E) after ketamine administration on ophthalmic surgery on the
           common conditions of geriatric patients, —comorbid and settings as minor surgery—.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be patients programmed for a vitrectomy or cataract surgery involving a
      retrobulbar block, to be carried out with a local anesthesia.

      - Administration of ketamine will be suspended during the study for any cause considered as a
      risk to the patient according to the judgment of the researchers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline to postoperative endpoint error scores on the Short Portable Mental Status Questionnaire (SPMSQ) in both groups</measure>
    <time_frame>Baseline, 2 hours after surgery</time_frame>
    <description>Patients were included in an analysis of mean change from preoperative to postoperative assessment of the number of items missed on the SPMSQ using analysis of covariance (ANCOVA) model which contained baseline status as covariate, and the treatment group as the effect of interest.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Hemodynamic measures</measure>
    <time_frame>Baseline, after Retrobulbar block , 90 minutes into surgery.</time_frame>
    <description>Analysis of changes over time in hemodynamic parameters was done during the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in respiratory rate measures</measure>
    <time_frame>Baseline, after Retrobulbar block , 90 minutes into surgery.</time_frame>
    <description>Analysis of changes over time in respiratory rate was done during the surgery with a general lineal model.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in oxygen saturation measures</measure>
    <time_frame>Baseline, after Retrobulbar block , 90 minutes into surgery.</time_frame>
    <description>Analysis of changes over time in oxygen saturation measures was done during the surgery with a general lineal model</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ramsey Sedation Scale</measure>
    <time_frame>Baseline, after retrobulbar block, 90 minutes into surgery</time_frame>
    <description>Sedation according to the Ramsey Scale from baseline to the final assessment (90minutes into surgery), was done with a general lineal model.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change on intraocular pressure measures</measure>
    <time_frame>Baseline (previous Retrobulbar block), end of surgery.</time_frame>
    <description>Analysis of change in intraocular pressure over time was done previous retrobulbar block and at the end of surgery with a general lineal model over non-surgical eye.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesia</measure>
    <time_frame>Changes in analgesia after regional anaesthesia (retrobulbar block). Changes in analgesia over 30 minutes after surgery.</time_frame>
    <description>Analgesia was evaluated after regional anesthesia (retrobulbar block) and after surgery, a comparison was made between groups by the Chi-squared test (χ2).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Ketamine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine: (dose 0.3 mcg/kg) included in physiological solution at 0.9% (250 ml) during 2 hours, intravenously.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>physiological solution</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Control group: only physiological solution at 0.9% (250 ml) during 2 hours, intravenously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Ketamine: (dose 0.3 mcg/kg) included in physiological solution at 0.9% (250 ml) during 2 hours, intravenously.</description>
    <arm_group_label>Ketamine group</arm_group_label>
    <other_name>Ketalin</other_name>
    <other_name>Ketalar</other_name>
    <other_name>Ketanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>physiological solution</intervention_name>
    <description>physiological solution at 0.9% (250 ml) during 2 hours, intravenously, with the same physical characteristics of ketamine.</description>
    <arm_group_label>Ketamine group</arm_group_label>
    <arm_group_label>physiological solution</arm_group_label>
    <other_name>Control</other_name>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients be over 60 years and older.

          -  Intraocular pressure less than 20 millimeter of mercury.

          -  American Society of Anaesthesiologists (ASA) physical status classification, I-III.

        Exclusion Criteria:

          -  History of psychosis or schizophrenia.

          -  Nephropathy.

          -  Difficult to control hypertension.

          -  Uncontrolled hepatic disorders.

          -  Allergy to ketamine.

          -  Moderate to severe depression.

          -  Post-operative delirium.

          -  Needed to use medications other than those contemplated in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dulce M. Rascon, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria E. Ocharan, PhD.</last_name>
    <role>Study Director</role>
    <affiliation>Instituto Politecnico Nacional</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Fresan, PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Psiquiatria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge H. Genis, Geriatrician</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Castellanos, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Mexicano del Seguro Social</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro Medico Nacional Siglo XXI. UMAE Hospital de Especialidades</name>
      <address>
        <city>Mexico</city>
        <state>Distrito Federal</state>
        <zip>06720</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Tolep K, Higgins N, Muza S, Criner G, Kelsen SG. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med. 1995 Aug;152(2):677-82.</citation>
    <PMID>7633725</PMID>
  </reference>
  <reference>
    <citation>Phillips-Bute B, Mathew JP, Blumenthal JA, Grocott HP, Laskowitz DT, Jones RH, Mark DB, Newman MF. Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med. 2006 May-Jun;68(3):369-75.</citation>
    <PMID>16738066</PMID>
  </reference>
  <reference>
    <citation>Jones MJ, Piggott SE, Vaughan RS, Bayer AJ, Newcombe RG, Twining TC, Pathy J, Rosen M. Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement. BMJ. 1990 Jun 30;300(6741):1683-7.</citation>
    <PMID>2390547</PMID>
  </reference>
  <reference>
    <citation>Tsai TL, Sands LP, Leung JM. An Update on Postoperative Cognitive Dysfunction. Adv Anesth. 2010;28(1):269-284.</citation>
    <PMID>21151735</PMID>
  </reference>
  <reference>
    <citation>Caba F, Echevarría M, Cruz A, Rodríguez E, Llamas JM, Martínez MD, Rodríguez R. [Postoperative mental confusion in the elderly with hip fracture. Perioperative risk factors]. Rev Esp Anestesiol Reanim. 1994 Sep-Oct;41(5):255-61. Spanish.</citation>
    <PMID>7991903</PMID>
  </reference>
  <reference>
    <citation>Malouf R, Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev. 2003;(3):CD004326. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD004326.</citation>
    <PMID>12918012</PMID>
  </reference>
  <reference>
    <citation>Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med. 2007 Jan 8;167(1):21-30. Review.</citation>
    <PMID>17210874</PMID>
  </reference>
  <reference>
    <citation>Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth. 2010 Feb;24(1):131-42. doi: 10.1053/j.jvca.2009.05.008. Epub 2009 Jul 29. Review.</citation>
    <PMID>19640746</PMID>
  </reference>
  <reference>
    <citation>Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989 May 19;244(4906):798-800.</citation>
    <PMID>2567056</PMID>
  </reference>
  <reference>
    <citation>Hartvig P, Valtysson J, Lindner KJ, Kristensen J, Karlsten R, Gustafsson LL, Persson J, Svensson JO, Oye I, Antoni G, et al. Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther. 1995 Aug;58(2):165-73.</citation>
    <PMID>7648766</PMID>
  </reference>
  <reference>
    <citation>Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975 Oct;23(10):433-41.</citation>
    <PMID>1159263</PMID>
  </reference>
  <reference>
    <citation>Gonzalez Montalvo J I; Rodriguez L; Ruiperez I. Validacion del cuestionario de Pfeiffer y la escala de incapacidad mental de la cruz roja en la deteccion del deterioro mental en los pacientes externos de un servicio de Geriatria. Revista Española de Geriatría y Gerontología. 1991, 27 (3): 129-133.</citation>
  </reference>
  <reference>
    <citation>Attix Deborah K, Welsh-Bohmer Kathleen A: Geriatric Neuropsychology: assessment and intervention. Guilford Press, 2006.</citation>
  </reference>
  <results_reference>
    <citation>Hudetz JA, Iqbal Z, Gandhi SD, Patterson KM, Byrne AJ, Hudetz AG, Pagel PS, Warltier DC. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand. 2009 Aug;53(7):864-72. doi: 10.1111/j.1399-6576.2009.01978.x. Epub 2009 Apr 28.</citation>
    <PMID>19422355</PMID>
  </results_reference>
  <results_reference>
    <citation>Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998 Mar 21;351(9106):857-61. Erratum in: Lancet 1998 Jun 6;351(9117):1742.</citation>
    <PMID>9525362</PMID>
  </results_reference>
  <results_reference>
    <citation>Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology. 1996 May;14(5):301-7.</citation>
    <PMID>8703299</PMID>
  </results_reference>
  <results_reference>
    <citation>Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994 Mar;51(3):199-214.</citation>
    <PMID>8122957</PMID>
  </results_reference>
  <results_reference>
    <citation>Roytblat L, Talmor D, Rachinsky M, Greemberg L, Pekar A, Appelbaum A, Gurman GM, Shapira Y, Duvdenani A. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg. 1998 Aug;87(2):266-71.</citation>
    <PMID>9706914</PMID>
  </results_reference>
  <results_reference>
    <citation>Bartoc C, Frumento RJ, Jalbout M, Bennett-Guerrero E, Du E, Nishanian E. A randomized, double-blind, placebo-controlled study assessing the anti-inflammatory effects of ketamine in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2006 Apr;20(2):217-22. Epub 2006 Mar 9. Retraction in: J Cardiothorac Vasc Anesth. 2014 Oct;28(5):1435.</citation>
    <PMID>16616662</PMID>
  </results_reference>
  <results_reference>
    <citation>Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol. 1997 Feb;7(1):25-38.</citation>
    <PMID>9088882</PMID>
  </results_reference>
  <results_reference>
    <citation>Holcomb HH, Lahti AC, Medoff DR, Weiler M, Tamminga CA. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology. 2001 Aug;25(2):165-72.</citation>
    <PMID>11425500</PMID>
  </results_reference>
  <results_reference>
    <citation>Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 1995 Aug;13(1):9-19.</citation>
    <PMID>8526975</PMID>
  </results_reference>
  <results_reference>
    <citation>Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology. 1972 Jan;36(1):69-75.</citation>
    <PMID>5006989</PMID>
  </results_reference>
  <results_reference>
    <citation>O'Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997 Jun;20(6):252-8. Review.</citation>
    <PMID>9185306</PMID>
  </results_reference>
  <results_reference>
    <citation>Shen C, Nettleton D, Jiang M, Kim SK, Powell-Coffman JA. Roles of the HIF-1 hypoxia-inducible factor during hypoxia response in Caenorhabditis elegans. J Biol Chem. 2005 May 27;280(21):20580-8. Epub 2005 Mar 21.</citation>
    <PMID>15781453</PMID>
  </results_reference>
  <results_reference>
    <citation>Sakai T, Ichiyama T, Whitten CW, Giesecke AH, Lipton JM. Ketamine suppresses endotoxin-induced NF-kappaB expression. Can J Anaesth. 2000 Oct;47(10):1019-24.</citation>
    <PMID>11032280</PMID>
  </results_reference>
  <results_reference>
    <citation>Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-83. Review.</citation>
    <PMID>8717528</PMID>
  </results_reference>
  <results_reference>
    <citation>Kochs E, Werner C, Hoffman WE, Möllenberg O, Schulte am Esch J. Concurrent increases in brain electrical activity and intracranial blood flow velocity during low-dose ketamine anaesthesia. Can J Anaesth. 1991 Oct;38(7):826-30.</citation>
    <PMID>1742815</PMID>
  </results_reference>
  <results_reference>
    <citation>Långsjö JW, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Sipilä H, Kurki T, Silvanto M, Scheinin H. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003 Sep;99(3):614-23.</citation>
    <PMID>12960545</PMID>
  </results_reference>
  <results_reference>
    <citation>Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000 Feb 15;47(4):351-4.</citation>
    <PMID>10686270</PMID>
  </results_reference>
  <results_reference>
    <citation>Kudoh A, Takahira Y, Katagai H, Takazawa T. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg. 2002 Jul;95(1):114-8, table of contents.</citation>
    <PMID>12088953</PMID>
  </results_reference>
  <results_reference>
    <citation>Sadove MS, Shulman M, Hatano S, Fevold N. Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg. 1971 May-Jun;50(3):452-7.</citation>
    <PMID>5103784</PMID>
  </results_reference>
  <results_reference>
    <citation>Bell RF. Ketamine for chronic non-cancer pain. Pain. 2009 Feb;141(3):210-4. doi: 10.1016/j.pain.2008.12.003. Epub 2009 Jan 6. Review.</citation>
    <PMID>19128879</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlaeyen JW, Linton SJ. Are we &quot;fear-avoidant&quot;? Pain. 2006 Oct;124(3):240-1. Epub 2006 Aug 9.</citation>
    <PMID>16901646</PMID>
  </results_reference>
  <results_reference>
    <citation>Loots H, Wiseman R. Ophthalmic anaesthesia, agents for sedation in ophthalmic surgery: A review of the pharmacodynamics and clinical applications. Current Anaesthesia&amp; Critical Care (2006) 17, 179-190</citation>
  </results_reference>
  <results_reference>
    <citation>Frey K, Sukhani R, Pawlowski J, Pappas AL, Mikat-Stevens M, Slogoff S. Propofol versus propofol-ketamine sedation for retrobulbar nerve block: comparison of sedation quality, intraocular pressure changes, and recovery profiles. Anesth Analg. 1999 Aug;89(2):317-21.</citation>
    <PMID>10439740</PMID>
  </results_reference>
  <results_reference>
    <citation>Santiveri X, Moltò L, Rodríguez C, Sandín F, Vilaplana J, Castillo J. [Sedation and analgesia with propofol plus low-dose ketamine for retrobulbar block]. Rev Esp Anestesiol Reanim. 2006 Nov;53(9):545-9. Spanish.</citation>
    <PMID>17297830</PMID>
  </results_reference>
  <results_reference>
    <citation>Moorthy SS, Valluri S, editors. Retrobulbar anesthesia—letters to the editor. Ophthalmology 2002;109(1):4-8.</citation>
  </results_reference>
  <results_reference>
    <citation>Slogoff S, Allen GW, Wessels JV, Cheney DH. Clinical experience with subanesthetic ketamine. Anesth Analg. 1974 May-Jun;53(3):354-8.</citation>
    <PMID>4856927</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2014</study_first_submitted>
  <study_first_submitted_qc>January 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2014</study_first_posted>
  <last_update_submitted>November 23, 2014</last_update_submitted>
  <last_update_submitted_qc>November 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Mexicano del Seguro Social</investigator_affiliation>
    <investigator_full_name>Dulce Maria Rascon Martinez</investigator_full_name>
    <investigator_title>Anesthesiology - Pain Clinical professor.</investigator_title>
  </responsible_party>
  <keyword>Ketamine</keyword>
  <keyword>acute cognitive dysfunction</keyword>
  <keyword>geriatric patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

